Researchers from MIT and Scripps have unveiled a promising new HIV vaccine approach that generates a powerful immune response with just one dose. By combining two immune-boosting adjuvants alum and SMNP the vaccine lingers in lymph nodes for nearly a month, encouraging the body to produce a vast array of antibodies. This one-shot strategy could revolutionize how we fight not just HIV, but many infectious diseases. It mimics the natural infection process and opens the door to broadly neutralizing antibody responses, a holy grail in vaccine design. And best of all, it's built on components already known to medicine.
from Top Health News -- ScienceDaily https://ift.tt/sezFikA
the news of the day, for today, top news of today, world news today live, top local news, top news stories of the day, top news today in the world, news today nyc, top news today local,
Subscribe to:
Post Comments (Atom)
Statins may help almost everyone with type 2 diabetes live longer
New research suggests statins may protect adults with type 2 diabetes regardless of how low their predicted heart risk appears. In a large U...
-
Researchers from MIT and Scripps have unveiled a promising new HIV vaccine approach that generates a powerful immune response with just one ...
-
Three treaties between the US and Hong Kong were suspended, the latest move to pressure China. from Yahoo News - Latest News & Headl...
-
Researchers observed a rise in adult central nervous system (CNS) infections, primarily aseptic meningitis caused by the varicella zoster vi...
No comments:
Post a Comment